Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurofilament Light Chain as Biomarker for Bortezomib-induced Peripheral Neuropathy

NCT05781425 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT05781425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05781425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurofilament Light Chain as Biomarker for Bortezomib-induced Peripheral Neuropathy
Lead sponsor
Odense University Hospital
Phase
Observational
Overall status
Completed
Start date
May 12, 2023
Completion date
July 29, 2025
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy